Indicated for the treatment of adults (>18 years of age) with mild, moderate and severe infections due to levofloxacin-susceptible microorganisms: (a) acute bacterial sinusitis; (b) acute bacterial exacerbations of chronic bronchitis; (c) community acquired pneumonia; (d) complicated urinary tract infections including pyelonephritis; (e) chronic bacterial prostatitis; and (f) skin and soft tissue infections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
